RNA结合蛋白DDX3X通过TLE2-MYL9轴驱动胰腺癌的进展
Yuanyang Wang1, Qianyi Yang2, Feng Lin3
1State Key Laboratory of Common Mechanism Research for Major Diseases, Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Science advances
|September 12, 2025
概括
胰腺癌 (PDAC) 的进展涉及生物力学线索. 针对涉及TLE2和MYL9的DEAD-box螺旋酶3X相关 (DDX3X) 途径,显著减少了PDAC的生长和转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物物理学的生物物理.
背景情况:
- 胰腺管腺癌 (PDAC) 的治疗方法不足,需要对其进展有更深入的了解.
- PDAC的进展涉及生物化学和生物机械因素.
研究的目的:
- 使用CRISPR-Cas9屏幕识别PDAC进展的关键调节者.
- 阐明RNA结合蛋白DEAD-box化酶3X结合 (DDX3X) 在PDAC生物力学和转移中的作用.
主要方法:
- 在一个正位异种移植模型中使用CRISPR-Cas9屏幕来分析PDAC动态.
- 研究了在PDAC中将DDX3X,TLE2,KLF4和MYL9连接在一起的分子机制.
主要成果:
- 确定DDX3X作为PDAC中的关键瘤基因和生物机械检查点.
- DDX3X的上调会破坏TLE2mRNA的稳定,破坏TLE2-KLF4的相互作用,并增加MYL9的表达.
- 增加MYL9表达改变F-actin,增强细胞引力和促进转移.
结论:
- DDX3X-TLE2-MYL9通路是PDAC进展和转移的关键驱动因素.
- 通过解决生物力学线索,针对这种途径为胰腺癌提供了一个有希望的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Canonical Wnt Signaling Pathway
10.4K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.4K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K


